Prof John Eu-Li WONG
Senior Vice President (Health Affairs)
Isabel Chan Professor in Medical Sciences
Professor John Eu-Li Wong, Isabel Chan Professor in Medical Sciences, is Senior Vice President (Health Affairs) of the National University of Singapore. He is also the Chief Executive of the National University Health System and Director of the National University Cancer Institute, Singapore.
A medical oncologist-haematologist, Prof Wong obtained his MBBS from NUS and did his residency and fellowship at the New York Hospital-Cornell Medical Center, where he was the Chief Resident in Medicine, and Memorial Sloan-Kettering Cancer Center.
He is actively involved in the development of Biomedical Sciences as a key pillar of Singapore's economy, as well as the development of Singapore's first academic health system linking the National University Hospital and NUS' medical, public health, dental, and nursing schools under one unified governance. Prof Wong represents Singapore in the M8 Alliance of Academic Health Centers and the Association of Academic Health Centers – International. He is a member of the World Economic Forum Global Agenda Council on Personalized and Precision Medicine, the Nature Index Panel of Senior Medical Advisors, the International Editorial Board of the American Journal of Medicine, and the Editorial Board of the Journal of the American Medical Association. He jointly founded the Cancer Therapeutics Research Group, a multinational consortium of nine academic institutions, and has served as a member of the International Education Council for Molecular Targeted Therapy for Cancer, the American Society of Clinical Oncology International Affairs Committee, and the International Oncology Foundation Advisory Board.
Prof Wong's research interests are in the development of new drugs, new treatment strategies and differences between Asian and Caucasian cancers.
He was awarded the Public Administration Medal (Silver) in 2005 and the National Outstanding Clinician Award in 2009 in recognition of his contributions to medicine and clinical research. He also received the SASS Foundation award in 2010 in recognition of his outstanding contributions in advancing the field of Hematology Oncology. In 2013, he received the Outstanding Service Award from NUS.